Commentary

Video

Dr Möller on Gender Biases in Oncology

Mecker G. Möller, MD, discusses the importance of addressing gender biases in oncology.

Mecker G. Möller, MD, professor of Surgery, Director, Regional Therapies Program, director, Surgical Oncology Fellowship Program, The University of Chicago Medicine, discusses the importance of addressing gender biases in oncology.

Möller begins by stating that she believes the primary way to address gender disparities for women working in oncology is through the acknowledgement of the existence of these biases. Often, accepting the status quo can prevent the identification of potential biases and ways to impart impactful change, she states. However, this acceptance is not necessary, as current systems inherently contain gender biases, Möller explains, noting that it is crucial to learn to identify these biases and advocate for improvements.

Möller states that she has been fortunate to find mentors who supported her during challenging times when the system wasn't accommodating. These mentors—professional women established in the oncology field—provided invaluable advice and guidance, she elucidates. One particularly impactful mentor Möller says she had was a woman who eventually became a chair in her field. Witnessing her integrity and the respect she garnered for her work was truly inspiring, according to Möller. However, it's also disheartening to see accomplished women like her facing unfairness within the system, she notes. Nevertheless, it has been uplifting to witness these women persisting as trailblazers despite the obstacles, pushing for equality for future generations, Möller continues, saying that she aspires to do the same for the women who come after her. The journey toward gender equality isn't without its challenges; it requires continual recognition of biases and systemic injustices, along with concerted efforts to challenge and change them, Möller emphasizes. 

It's crucial for individuals to advocate for themselves and seek out supportive networks and mentors who can provide guidance and encouragement along the way, she continues. By learning from the experiences of those who have navigated similar paths and by being inspired by their resilience and determination, a universal effort can be made to create a more equitable future for women in oncology, Möller concludes.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD